Glucose consumption of inflammatory cells masks metabolic deficits in the brain
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Inflammatory cells such as microglia need energy to exert their functions and to maintain their cellular integrity and membrane potential. Subsequent to cerebral ischemia, inflammatory cells infiltrate tissue with limited blood flow where neurons and astrocytes died due to insufficient supply with oxygen and glucose. Using dual tracer positron emission tomography (PET), we found that concomitant with the presence of inflammatory cells, transport and consumption of glucose increased up to normal levels but returned to pathological levels as soon as inflammatory cells disappeared. Thus, inflammatory cells established sufficient glucose supply to satisfy their energy demands even in regions with insufficient supply for neurons and astrocytes to survive. Our data suggest that neurons and astrocytes died from oxygen deficiency and inflammatory cells metabolized glucose non-oxidatively in regions with residual availability. As a consequence, glucose metabolism of inflammatory cells can mask metabolic deficits in neurodegenerative diseases. We further found that the PET tracer did not bind to inflammatory cells in severely hypoperfused regions and thus only a part of the inflammation was detected. We conclude that glucose consumption of inflammatory cells should be taken into account when analyzing disease-related alterations of local cerebral metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 1×
“Microglia also have the capacity to become polarized intoM1-like andM2-like phenotypes (Prinz and Priller, 2014).”
Graeber, M. B. (2010) · Science · doi:10.1126/science.1190929 · Cited by 608 · cited 1×
“Harmful or beneficial — disorders of the brain may induce neuroinflammation affecting the course of disease (Graeber and Streit, 2010; Graeber, 2010).”
Visualising microglial activation in vivo
Banati, R. B. (2002) · Glia · doi:10.1002/glia.10144 · Cited by 428
Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain
Bittar, P. G., Charnay, Y., Pellerin, L., Bouras, C., & Magistretti, P. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199611000-00001 · Cited by 423 · cited 1×
“…of neurons, astrocytes, and oligodendrocytes (negative staining for NeuN, GFAP, Olig2), exclusively populated by immune cells (all cells Ox-42 and Iba1 positive), which were co-located with the staining for LDH-5, the enzyme that drives lactate production from pyruvate (Bittar et al., 1996) (Fig.”
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability
Politis, M., Giannetti, P., Su, P., Turkheimer, F., Keihaninejad, S., Wu, K., Waldman, A., Malik, O., Matthews, P. M., Reynolds, R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182635645 · Cited by 176
Cited by
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities
Candelario-Jalil, E., Dijkhuizen, R. M., & Magnus, T. (2022) · Stroke · doi:10.1161/strokeaha.122.036946 · Cited by 953
A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease
Baik, S. H., Kang, S., Lee, W., Choi, H., Chung, S., Kim, J.-I., & Mook-Jung, I. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.005 · Cited by 843
Glucose transporter 1 critically controls microglial activation through facilitating glycolysis
Wang, L., Pavlou, S., Du, X., Bhuckory, M., Xu, H., & Chen, M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0305-9 · Cited by 335
Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer’s Disease
Fairley, L. H., Wong, J. H., & Barron, A. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624538 · Cited by 120
“Nutrient Availability and Metabolic Stress The AD brain is under metabolic stress, with impairments in nutrient availability including glucose occurring early in the disease due to impaired blood-brain glucose transfer (34, 37).”
BackgroundAxonal energy metabolism, and the effects in aging and neurodegenerative diseases
Yang, S., Park, J. H., & Lu, H.-C. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00634-3 · Cited by 94
“Furthermore, the remyelinating and immune reactive process in oligodendrocytes seem to be energy demanding [413, 414], potentially competing for the glucose metabolism substrates and therefore worsening the axonal bioenergetics.”
Background
Metadata
- Authors
- Backes, H., Walberer, M., Ladwig, A., Rueger, M. A., Neumaier, B., Endepols, H., Hoehn, M., Fink, G. R., Schroeter, M., & Graf, R.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 128
- Pages
- 54-62
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2204761283
- Cited by
- 69
- References
- 5
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucose consumption of inflammatory cells masks metabolic deficits in the brain. https://app.cochat.ai/papers/10.1016/j.neuroimage.2015.12.044
- The paper
- Backes, H., Walberer, M., Ladwig, A., Rueger, M. A., Neumaier, B., Endepols, H., Hoehn, M., Fink, G. R., Schroeter, M., & Graf, R. (2016). Glucose consumption of inflammatory cells masks metabolic deficits in the brain. NeuroImage. https://doi.org/10.1016/j.neuroimage.2015.12.044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.